Efficacy and Safety of VDPHL01 in Males With AGA
Study sponsor: Veradermics, Inc. · MANE
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-02Estimated
Enrollment · participants480Estimated
Source updated2025-11-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.